Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Jun 8. pii: dci190028. doi: 10.2337/dci19-0028. [Epub ahead of print]

PMID:
31177185
2.

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.

Bosi E, Choudhary P, de Valk HW, Lablanche S, Castañeda J, de Portu S, Da Silva J, Ré R, Vorrink-de Groot L, Shin J, Kaufman FR, Cohen O; SMILE Study Group.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):462-472. doi: 10.1016/S2213-8587(19)30150-0. Epub 2019 Apr 29.

PMID:
31047902
3.

Less Is More: Genome Reduction and the Emergence of Cooperation-Implications into the Coevolution of Microbial Communities.

Bosi E, Mascagni F.

Int J Genomics. 2019 Feb 17;2019:2659175. doi: 10.1155/2019/2659175. eCollection 2019. Review.

4.

Guido Pozza M.D.: a visionary scholar.

Folli F, Secchi A, La Rocca E, Bosi E, Pontiroli AE.

Acta Diabetol. 2019 Jan;56(1):3-5. doi: 10.1007/s00592-018-1269-x. No abstract available.

PMID:
30569237
5.

Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.

De Valk HW, Lablanche S, Bosi E, Choudhary P, Silva JD, Castaneda J, Vorrink L, De Portu S, Cohen O.

Diabetes Technol Ther. 2018 Nov;20(11):758-766. doi: 10.1089/dia.2018.0222. Epub 2018 Oct 16.

PMID:
30325656
6.

Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes.

Vecchio F, Lo Buono N, Stabilini A, Nigi L, Dufort MJ, Geyer S, Rancoita PM, Cugnata F, Mandelli A, Valle A, Leete P, Mancarella F, Linsley PS, Krogvold L, Herold KC, Elding Larsson H, Richardson SJ, Morgan NG, Dahl-Jørgensen K, Sebastiani G, Dotta F, Bosi E; DRI_Biorepository Group; Type 1 Diabetes TrialNet Study Group, Battaglia M.

JCI Insight. 2018 Sep 20;3(18). pii: 122146. doi: 10.1172/jci.insight.122146. eCollection 2018 Sep 20.

7.

A novel LIPS assay for insulin autoantibodies.

Liberati D, Wyatt RC, Brigatti C, Marzinotto I, Ferrari M, Bazzigaluppi E, Bosi E, Gillard BT, Gillespie KM, Gorus F, Weets I, Balti E, Piemonti L, Achenbach P, Williams AJK, Lampasona V.

Acta Diabetol. 2018 Mar;55(3):263-270. doi: 10.1007/s00592-017-1082-y. Epub 2018 Jan 5.

PMID:
29305766
8.

Integration of Comparative Genomics with Genome-Scale Metabolic Modeling to Investigate Strain-Specific Phenotypical Differences.

Monk J, Bosi E.

Methods Mol Biol. 2018;1716:151-175. doi: 10.1007/978-1-4939-7528-0_7.

PMID:
29222753
9.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

10.

Gian Franco Bottazzo, 1946-2017.

Bonifacio E, Bosi E, Leslie RD.

Diabetologia. 2018 Jan;61(1):3-5. doi: 10.1007/s00125-017-4486-x. No abstract available.

11.

Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance.

Perrin E, Fondi M, Bosi E, Mengoni A, Buroni S, Scoffone VC, Valvano M, Fani R.

BMC Genomics. 2017 Oct 30;18(1):834. doi: 10.1186/s12864-017-4222-4.

12.

Basal insulin therapy is associated with beneficial effects on postoperative infective complications, independently from circulating glucose levels in patients admitted for cardiac surgery.

Piatti PM, Cioni M, Magistro A, Villa V, Crippa VG, Galluccio E, Fontana B, Spadoni S, Bosi E, Monti LD, Alfieri O.

J Clin Transl Endocrinol. 2017 Feb 11;7:47-53. doi: 10.1016/j.jcte.2017.01.005. eCollection 2017 Mar.

13.

Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific.

Marzinotto I, Liberati D, Brigatti C, Bonfanti R, Stabilini A, Monti P, Bosi E, Piemonti L, Lampasona V.

Diabetologia. 2017 Sep;60(9):1834-1835. doi: 10.1007/s00125-017-4376-2. Epub 2017 Jul 19. No abstract available.

PMID:
28725911
14.

Perspectives and Challenges in Microbial Communities Metabolic Modeling.

Bosi E, Bacci G, Mengoni A, Fondi M.

Front Genet. 2017 Jun 21;8:88. doi: 10.3389/fgene.2017.00088. eCollection 2017.

15.

New Genome Sequence of an Echinaceapurpurea Endophyte, Arthrobacter sp. Strain EpSL27, Able To Inhibit Human-Opportunistic Pathogens.

Miceli E, Presta L, Maggini V, Fondi M, Bosi E, Chiellini C, Fagorzi C, Bogani P, Di Pilato V, Rossolini GM, Mengoni A, Firenzuoli F, Perrin E, Fani R.

Genome Announc. 2017 Jun 22;5(25). pii: e00565-17. doi: 10.1128/genomeA.00565-17.

16.

Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.

Presta L, Bosi E, Mansouri L, Dijkshoorn L, Fani R, Fondi M.

Sci Rep. 2017 Jun 16;7(1):3706. doi: 10.1038/s41598-017-03416-2.

17.

Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.

Bosi E, Boulware DC, Becker DJ, Buckner JH, Geyer S, Gottlieb PA, Henderson C, Kinderman A, Sosenko JM, Steck AK, Bingley PJ; Type 1 Diabetes TrialNet Study Group.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2881-2886. doi: 10.1210/jc.2017-00569.

18.

Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P.

Diabetes Technol Ther. 2017 Jul;19(7):391-399. doi: 10.1089/dia.2017.0054. Epub 2017 May 22. Review.

19.

Draft Genome Sequence of Pseudomonas sp. Strain Ep R1 Isolated from Echinacea purpurea Roots and Effective in the Growth Inhibition of Human Opportunistic Pathogens Belonging to the Burkholderia cepacia Complex.

Maggini V, Presta L, Miceli E, Fondi M, Bosi E, Chiellini C, Fagorzi C, Bogani P, Di Pilato V, Rossolini GM, Mengoni A, Firenzuoli F, Perrin E, Fani R.

Genome Announc. 2017 May 18;5(20). pii: e00351-17. doi: 10.1128/genomeA.00351-17.

20.

Ecology of cold environments: new insights of bacterial metabolic adaptation through an integrated genomic-phenomic approach.

Mocali S, Chiellini C, Fabiani A, Decuzzi S, de Pascale D, Parrilli E, Tutino ML, Perrin E, Bosi E, Fondi M, Lo Giudice A, Fani R.

Sci Rep. 2017 Apr 12;7(1):839. doi: 10.1038/s41598-017-00876-4.

21.

Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota.

Pellegrini S, Sordi V, Bolla AM, Saita D, Ferrarese R, Canducci F, Clementi M, Invernizzi F, Mariani A, Bonfanti R, Barera G, Testoni PA, Doglioni C, Bosi E, Piemonti L.

J Clin Endocrinol Metab. 2017 May 1;102(5):1468-1477. doi: 10.1210/jc.2016-3222.

PMID:
28324102
22.

Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.

Chiellini C, Maida I, Maggini V, Bosi E, Mocali S, Emiliani G, Perrin E, Firenzuoli F, Mengoni A, Fani R.

Microbiol Res. 2017 Mar;196:34-43. doi: 10.1016/j.micres.2016.12.001. Epub 2016 Dec 15.

23.

Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients.

Lahner E, Brigatti C, Marzinotto I, Carabotti M, Scalese G, Davidson HW, Wenzlau JM, Bosi E, Piemonti L, Annibale B, Lampasona V.

Clin Transl Gastroenterol. 2017 Jan 19;8(1):e215. doi: 10.1038/ctg.2016.71.

24.

The pangenome of (Antarctic) Pseudoalteromonas bacteria: evolutionary and functional insights.

Bosi E, Fondi M, Orlandini V, Perrin E, Maida I, de Pascale D, Tutino ML, Parrilli E, Lo Giudice A, Filloux A, Fani R.

BMC Genomics. 2017 Jan 17;18(1):93. doi: 10.1186/s12864-016-3382-y.

25.

Phenotypic and genomic characterization of the antimicrobial producer Rheinheimera sp. EpRS3 isolated from the medicinal plant Echinacea purpurea: insights into its biotechnological relevance.

Presta L, Bosi E, Fondi M, Maida I, Perrin E, Miceli E, Maggini V, Bogani P, Firenzuoli F, Di Pilato V, Rossolini GM, Mengoni A, Fani R.

Res Microbiol. 2017 Apr;168(3):293-305. doi: 10.1016/j.resmic.2016.11.001. Epub 2016 Nov 22.

PMID:
27884784
26.

Modelling microbial metabolic rewiring during growth in a complex medium.

Fondi M, Bosi E, Presta L, Natoli D, Fani R.

BMC Genomics. 2016 Nov 24;17(1):970.

27.

Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.

Balzano G, Dugnani E, Gandolfi A, Scavini M, Pasquale V, Aleotti F, Liberati D, Di Terlizzi G, Petrella G, Reni M, Doglioni C, Bosi E, Falconi M, Piemonti L.

PLoS One. 2016 Nov 4;11(11):e0166008. doi: 10.1371/journal.pone.0166008. eCollection 2016.

28.

Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma.

Dugnani E, Balzano G, Pasquale V, Scavini M, Aleotti F, Liberati D, Di Terlizzi G, Gandolfi A, Petrella G, Reni M, Doglioni C, Bosi E, Falconi M, Piemonti L.

Acta Diabetol. 2016 Dec;53(6):945-956. doi: 10.1007/s00592-016-0893-6. Epub 2016 Aug 23.

PMID:
27552832
29.

Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.

Dugnani E, Gandolfi A, Balzano G, Scavini M, Pasquale V, Aleotti F, Liberati D, Di Terlizzi G, Petrella G, Reni M, Doglioni C, Bosi E, Falconi M, Piemonti L.

Pancreatology. 2016 Sep-Oct;16(5):844-52. doi: 10.1016/j.pan.2016.08.005. Epub 2016 Aug 11.

PMID:
27546476
30.

Draft Genome Sequences of the Antimicrobial Producers Pseudomonas sp. TAA207 and Pseudomonas sp. TAD18 Isolated from Antarctic Sediments.

Presta L, Inzucchi I, Bosi E, Fondi M, Perrin E, Maida I, Miceli E, Tutino ML, Lo Giudice A, de Pascale D, Fani R.

Genome Announc. 2016 Jul 28;4(4). pii: e00728-16. doi: 10.1128/genomeA.00728-16.

31.

The evolving frontier of diabetes therapy: The renaissance of glycemology.

Ceriello A, Genovese S, Bosi E.

Diabetes Res Clin Pract. 2016 Aug;118:168-71. doi: 10.1016/j.diabres.2016.04.036. Epub 2016 Jun 20.

PMID:
27379449
32.

The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study.

Russo GT, Scavini M, Acmet E, Bonizzoni E, Bosi E, Giorgino F, Tiengo A, Cucinotta D.

Diabetes Technol Ther. 2016 Jul;18(7):421-8. doi: 10.1089/dia.2015.0358. Epub 2016 Jun 21.

33.

Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity.

Bosi E, Monk JM, Aziz RK, Fondi M, Nizet V, Palsson BØ.

Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3801-9. doi: 10.1073/pnas.1523199113. Epub 2016 Jun 10.

34.

Draft Genome Sequence of Flavobacterium sp. Strain TAB 87, Able To Inhibit the Growth of Cystic Fibrosis Bacterial Pathogens Belonging to the Burkholderia cepacia Complex.

Presta L, Inzucchi I, Bosi E, Fondi M, Perrin E, Miceli E, Tutino ML, Lo Giudice A, de Pascale D, Fani R.

Genome Announc. 2016 May 19;4(3). pii: e00410-16. doi: 10.1128/genomeA.00410-16.

35.

"Every Gene Is Everywhere but the Environment Selects": Global Geolocalization of Gene Sharing in Environmental Samples through Network Analysis.

Fondi M, Karkman A, Tamminen MV, Bosi E, Virta M, Fani R, Alm E, McInerney JO.

Genome Biol Evol. 2016 May 13;8(5):1388-400. doi: 10.1093/gbe/evw077.

36.

Draft Genome Sequence of Pseudomonas sp. EpS/L25, Isolated from the Medicinal Plant Echinacea purpurea and Able To Synthesize Antimicrobial Compounds.

Presta L, Bosi E, Fondi M, Maida I, Perrin E, Miceli E, Maggini V, Bogani P, Firenzuoli F, Di Pilato V, Rossolini GM, Mengoni A, Fani R.

Genome Announc. 2016 May 5;4(3). pii: e00346-16. doi: 10.1128/genomeA.00346-16.

37.

Genomic and phenotypic characterization of the species Acinetobacter venetianus.

Fondi M, Maida I, Perrin E, Orlandini V, La Torre L, Bosi E, Negroni A, Zanaroli G, Fava F, Decorosi F, Giovannetti L, Viti C, Vaneechoutte M, Dijkshoorn L, Fani R.

Sci Rep. 2016 Feb 23;6:21985. doi: 10.1038/srep21985.

38.

Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience.

Trevisan R, Bonizzoni E, Bosi E, Ceriello A, Cucinotta D, Giorgino F, Tiengo A, Scavini M.

Nutr Metab Cardiovasc Dis. 2016 Feb;26(2):169-70. doi: 10.1016/j.numecd.2015.12.006. Epub 2015 Dec 21. No abstract available.

PMID:
26803592
39.

Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial.

Monti LD, Galluccio E, Fontana B, Spadoni S, Comola M, Marrocco Trischitta MM, Chiesa R, Comi G, Bosi E, Piatti P.

Metabolism. 2015 Nov;64(11):1582-91. doi: 10.1016/j.metabol.2015.08.015. Epub 2015 Aug 28.

PMID:
26385052
40.

Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research.

Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P.

Diabetes Care. 2015 Sep;38(9):1627-33. doi: 10.2337/dc14-2919. No abstract available.

PMID:
26294772
41.

Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation: A Case Report.

Martinenghi S, Caretto A, Losio C, Scavini M, Bosi E.

Medicine (Baltimore). 2015 Jun;94(24):e950. doi: 10.1097/MD.0000000000000950.

42.

Antagonistic interactions between endophytic cultivable bacterial communities isolated from the medicinal plant Echinacea purpurea.

Maida I, Chiellini C, Mengoni A, Bosi E, Firenzuoli F, Fondi M, Fani R.

Environ Microbiol. 2016 Sep;18(8):2357-65. doi: 10.1111/1462-2920.12911. Epub 2015 Jul 22.

PMID:
26013664
43.

MeDuSa: a multi-draft based scaffolder.

Bosi E, Donati B, Galardini M, Brunetti S, Sagot MF, Lió P, Crescenzi P, Fani R, Fondi M.

Bioinformatics. 2015 Aug 1;31(15):2443-51. doi: 10.1093/bioinformatics/btv171. Epub 2015 Mar 25.

PMID:
25810435
44.

Defining orthologs and pangenome size metrics.

Bosi E, Fani R, Fondi M.

Methods Mol Biol. 2015;1231:191-202. doi: 10.1007/978-1-4939-1720-4_13.

PMID:
25343867
45.

Improvement in clinical symptoms of scleredema diabeticorum by frequency-modulated electromagnetic neural stimulation: a case report.

Gandolfi A, Pontara A, Di Terlizzi G, Rizzo N, Nicoletti R, Scavini M, Galimberti G, Bosi E.

Diabetes Care. 2014 Nov;37(11):e233-4. doi: 10.2337/dc14-0730. No abstract available.

PMID:
25342834
46.

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).

Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R; NIRAD Study Group.

Eur J Endocrinol. 2014 Dec;171(6):697-704. doi: 10.1530/EJE-14-0342. Epub 2014 Sep 11.

PMID:
25213702
47.

Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.

Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P; DEFEND Investigator Group.

Diabetes Care. 2014 Oct;37(10):2746-54. doi: 10.2337/dc13-0327. Epub 2014 Jul 10.

48.

Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome.

Piatti P, Setola E, Galluccio E, Costa S, Fontana B, Stuccillo M, Crippa V, Cappelletti A, Margonato A, Bosi E, Monti LD.

Acta Diabetol. 2014 Oct;51(5):793-9. doi: 10.1007/s00592-014-0599-6. Epub 2014 Jun 17.

PMID:
24934227
49.

Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.

Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, Rawal R, Roef GL, Plantinga TS, Vermeulen SH, Lahti J, Simmonds MJ, Husemoen LL, Freathy RM, Shields BM, Pietzner D, Nagy R, Broer L, Chaker L, Korevaar TI, Plia MG, Sala C, Völker U, Richards JB, Sweep FC, Gieger C, Corre T, Kajantie E, Thuesen B, Taes YE, Visser WE, Hattersley AT, Kratzsch J, Hamilton A, Li W, Homuth G, Lobina M, Mariotti S, Soranzo N, Cocca M, Nauck M, Spielhagen C, Ross A, Arnold A, van de Bunt M, Liyanarachchi S, Heier M, Grabe HJ, Masciullo C, Galesloot TE, Lim EM, Reischl E, Leedman PJ, Lai S, Delitala A, Bremner AP, Philips DI, Beilby JP, Mulas A, Vocale M, Abecasis G, Forsen T, James A, Widen E, Hui J, Prokisch H, Rietzschel EE, Palotie A, Feddema P, Fletcher SJ, Schramm K, Rotter JI, Kluttig A, Radke D, Traglia M, Surdulescu GL, He H, Franklyn JA, Tiller D, Vaidya B, de Meyer T, Jørgensen T, Eriksson JG, O'Leary PC, Wichmann E, Hermus AR, Psaty BM, Ittermann T, Hofman A, Bosi E, Schlessinger D, Wallaschofski H, Pirastu N, Aulchenko YS, de la Chapelle A, Netea-Maier RT, Gough SC, Meyer Zu Schwabedissen H, Frayling TM, Kaufman JM, Linneberg A, Räikkönen K, Smit JW, Kiemeney LA, Rivadeneira F, Uitterlinden AG, Walsh JP, Meisinger C, den Heijer M, Visser TJ, Spector TD, Wilson SG, Völzke H, Cappola A, Toniolo D, Sanna S, Naitza S, Peeters RP.

PLoS Genet. 2014 Feb 27;10(2):e1004123. doi: 10.1371/journal.pgen.1004123. eCollection 2014 Feb.

50.

Dietary supplementation contributes to lifestyle improvement in hypercholesterolemic patients in real-life contexts.

Bruckert E, Masana L, Chapman MJ, Descamps O, Bosi E, Allaert FA.

Curr Med Res Opin. 2014 Jul;30(7):1309-16. doi: 10.1185/03007995.2014.890924. Epub 2014 Mar 20.

PMID:
24502771

Supplemental Content

Support Center